United States · Biotechnology startup
United States · Nodality
Nodality develops biologically-informed clinical treatments for patients with cancer and autoimmune diseases.
Funding reportedLast round: Undisclosed round
What company datasets say Nodality raised
Funding, as reported
Reported in all$62Min dollars
Rounds6
Last roundUndisclosed round
Last round dateJul 2012
Investors listed7
SEC Form D$32M sold, 5 filings, last Aug 2011
Founders and team
From the SEC filings it signed: 4 on the team.
- Alessandra P CesanoExecutive Officeri
- David P SpellmeyerExecutive Officeri
- David ParkinsonExecutive Officer, Directori
- Philip P McGarrigleExecutive Officeri
On the board, as filediAndrew P AllenDavid P SingerFred P CohenGary P NolanGreg P CritchfieldRisa P Stack
Biotechnology in United States
Startups like it
- SojournixWaltham · founded 2016Raised
- Receptor Life SciencesSeattle · founded 2017Raised
- Attune PharmaceuticalsNew York · founded 2018Raised
AbbVieNorth Chicago · founded 2012
GrailMenlo Park · founded 2015
EQRxCambridge · founded 2019- Cerevel TherapeuticsBoston · founded 2018
Royalty PharmaNew York · founded 1996
Is this your company?
Add your raise, your deck and your story, and put Nodality in front of investors. Or tell us what we have wrong.